Jim Simons Cyclerion Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.43 - $0.9 $41,658 - $87,192	-96,880 Reduced 52.77%	86,700 $38,000
Q4 2022 Feb 13, 2023	SELL	$0.42 - $18.8 $41,919 - $1.88 Million	-99,808 Reduced 35.22%	183,580 $120,000
Q3 2022 Nov 14, 2022	SELL	$0.58 - $18.2 $100,159 - $3.14 Million	-172,689 Reduced 37.86%	283,388 $244,000
Q2 2022 Aug 12, 2022	BUY	$0.47 - $1.29 $72,153 - $198,039	153,519 Added 50.74%	456,077 $250,000
Q1 2022 May 13, 2022	SELL	$0.96 - $1.78 $41,608 - $77,148	-43,342 Reduced 12.53%	302,558 $336,000
Q4 2021 Feb 11, 2022	BUY	$1.56 - $2.99 $426,816 - $818,064	273,600 Added 378.42%	345,900 $595,000
Q3 2021 Nov 12, 2021	SELL	$2.73 - $4.13 $579,972 - $877,393	-212,444 Reduced 74.61%	72,300 $222,000
Q2 2021 Aug 13, 2021	BUY	$2.18 - $4.29 $112,365 - $221,123	51,544 Added 22.1%	284,744 $1.11 Million
Q1 2021 May 13, 2021	BUY	$2.69 - $5.12 $579,157 - $1.1 Million	215,300 Added 1202.79%	233,200 $651,000
Q4 2020 Feb 10, 2021	BUY	$2.25 - $7.12 $40,275 - $127,448	17,900 New	17,900 $55,000
Q3 2020 Nov 13, 2020	SELL	$3.46 - $8.39 $294,100 - $713,150	-85,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$2.37 - $7.14 $69,201 - $208,480	29,199 Added 52.33%	85,000 $502,000
Q1 2020 May 14, 2020	BUY	$2.46 - $5.84 $137,270 - $325,877	55,801 New	55,801 $148,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $139M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.